143 related articles for article (PubMed ID: 20544053)
1. Managing diabetic peripheral neuropathic pain in primary care.
Kuritzky L
J Fam Pract; 2010 May; 59(5 Suppl):S15-22. PubMed ID: 20544053
[TBL] [Abstract][Full Text] [Related]
2. Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis.
Tanenberg RJ; Clemow DB; Giaconia JM; Risser RC
Pain Pract; 2014 Sep; 14(7):640-8. PubMed ID: 24152185
[TBL] [Abstract][Full Text] [Related]
3. Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain.
Argoff CE; Backonja MM; Belgrade MJ; Bennett GJ; Clark MR; Cole BE; Fishbain DA; Irving GA; McCarberg BH; McLean MJ
Mayo Clin Proc; 2006 Apr; 81(4 Suppl):S12-25. PubMed ID: 16608049
[TBL] [Abstract][Full Text] [Related]
4. Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
Marchettini P; Wilhelm S; Petto H; Tesfaye S; Tölle T; Bouhassira D; Freynhagen R; Cruccu G; Lledó A; Choy E; Kosek E; Micó JA; Späth M; Skljarevski V; Lenox-Smith A; Perrot S
Eur J Pain; 2016 Mar; 20(3):472-82. PubMed ID: 26311228
[TBL] [Abstract][Full Text] [Related]
5. Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States.
Yang M; Qian C; Liu Y
Pain Med; 2015 Nov; 16(11):2075-83. PubMed ID: 26118704
[TBL] [Abstract][Full Text] [Related]
6. Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial.
Selvarajah D; Petrie J; White D; Julious S; Bortolami O; Cooper C; Bradburn M; Loban A; Bowler H; Swaby L; Sutherland K; Tesfaye S;
Trials; 2018 Oct; 19(1):578. PubMed ID: 30348206
[TBL] [Abstract][Full Text] [Related]
7. Treating diabetic peripheral neuropathic pain.
Lindsay TJ; Rodgers BC; Savath V; Hettinger K
Am Fam Physician; 2010 Jul; 82(2):151-8. PubMed ID: 20642268
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with pain medication selection among patients diagnosed with diabetic peripheral neuropathic pain: a retrospective study.
Chen S; Wu N; Boulanger L; Fraser K; Zhao Z; Zhao Y
J Med Econ; 2011; 14(4):411-20. PubMed ID: 21615268
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic management of diabetic peripheral neuropathic pain.
Iyer S; Tanenberg RJ
Expert Opin Pharmacother; 2013 Sep; 14(13):1765-75. PubMed ID: 23800105
[TBL] [Abstract][Full Text] [Related]
10. An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
Wernicke JF; Wang F; Pritchett YL; Smith TR; Raskin J; D'Souza DN; Iyengar S; Chappell AS
Pain Med; 2007 Sep; 8(6):503-13. PubMed ID: 17716324
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacologic therapy in peripheral diabetic polyneuropathy].
Mihai B; Lăcătuşu C; Graur M; Cijevschi-Prelipcean C; Mihai C
Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):332-41. PubMed ID: 20700963
[TBL] [Abstract][Full Text] [Related]
12. Safety profile of treatment in diabetic peripheral neuropathic pain.
Robinson-Papp J; Simpson DM
Pain Med; 2007 Sep; 8 Suppl 2():S43-9. PubMed ID: 17714115
[TBL] [Abstract][Full Text] [Related]
13. [The clinic, diagnosis, complex treatment of diabetic polyneuropathy].
Terent'eva NV
Lik Sprava; 2012; (7):187-91. PubMed ID: 23350148
[TBL] [Abstract][Full Text] [Related]
14. Diabetic painful neuropathy: current and future treatment options.
Chong MS; Hester J
Drugs; 2007; 67(4):569-85. PubMed ID: 17352515
[TBL] [Abstract][Full Text] [Related]
15. Diabetic peripheral neuropathic pain: recognition and management.
Cole BE
Pain Med; 2007 Sep; 8 Suppl 2():S27-32. PubMed ID: 17714113
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
Perahia DG; Pritchett YL; Desaiah D; Raskin J
Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
[TBL] [Abstract][Full Text] [Related]
17. Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective study.
Zhao Y; Liu J; Zhao Y; Thethi T; Fonseca V; Shi L
Pain Pract; 2012 Jun; 12(5):366-73. PubMed ID: 21951753
[TBL] [Abstract][Full Text] [Related]
18. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management.
Tesfaye S; Vileikyte L; Rayman G; Sindrup SH; Perkins BA; Baconja M; Vinik AI; Boulton AJ;
Diabetes Metab Res Rev; 2011 Oct; 27(7):629-38. PubMed ID: 21695762
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
Tesfaye S; Wilhelm S; Lledo A; Schacht A; Tölle T; Bouhassira D; Cruccu G; Skljarevski V; Freynhagen R
Pain; 2013 Dec; 154(12):2616-2625. PubMed ID: 23732189
[TBL] [Abstract][Full Text] [Related]
20. [Experience with "AFAVIT Diabetes" used in the treatment of diabetic peripheral polyneuropathy in adolescents].
Azova EA; Vorob'eva VA; Chekalova SA; Okulova OV; Azov NA; Kolbasina EV; Belotserkovskaia OE; Severukhina TA; Sladkova IV
Ter Arkh; 2012; 84(12):82-4. PubMed ID: 23479996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
